The risk of hacking will never be completely wiped out, good practice in security and leveraging what is available about upcoming threats will empower users to be able to confidently navigate within ...

REGENXBIO Inc.  today reported new, positive interim data from two additional patients in the Phase I/II portion of the AFFINITY DUCHENNE® trial of RGX-202, a differentiated investigational gene ...

Approximately 40% of new leasing supply in 2024 has been absorbed according to a JLL report, leaving around 17,000 pings ...